TY  - GEN
AU  - Nieto, Patricia
AU  - Ambrogio, Chiara
AU  - Esteban-Burgos, Laura
AU  - Gómez-López, Gonzalo
AU  - Blasco, María Teresa
AU  - Yao, Zhan
AU  - Marais, Richard
AU  - Rosen, Neal
AU  - Chiarle, Roberto
AU  - Pisano, David G
AU  - Barbacid, Mariano
AU  - Santamaría, David
AU  - Nieto, Patricia
AU  - Ambrogio, Chiara
AU  - Esteban-Burgos, Laura
AU  - Gómez-López, Gonzalo
AU  - Blasco, María Teresa
AU  - Yao, Zhan
AU  - Marais, Richard
AU  - Rosen, Neal
AU  - Chiarle, Roberto
AU  - Pisano, David G
AU  - Santamaría, David
PY  - 2017
UR  - https://hdl.handle.net/20.500.12105/25313
AB  - The initiating oncogenic event in almost half of human lung adenocarcinomas is still unknown, a fact that complicates the development of selective targeted therapies. Yet these tumours harbour a number of alterations without obvious oncogenic function...
LA  - eng
PB  - Nature Publishing Group
KW  - TUMOR-SUPPRESSOR ACTIVITY
KW  - K-RAS ONCOGENE
KW  - MOUSE MODEL
KW  - C-RAF
KW  - B-RAF
KW  - CANCER
KW  - CELLS
KW  - PROTEIN
KW  - PROGRESSION
KW  - INHIBITORS
TI  - A Braf kinase-inactive mutant induces lung adenocarcinoma.
TY  - research article
ER  -